SOW
NGNE icon

State of Wyoming’s Neurogene NGNE Stock Holding History

State of Wyoming’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8K Buy
+980
New +$27K ﹤0.01% 1755
2021
Q3 		– Sell
-79
Closed -$15K – 1296
2021
Q2 		$15K Buy
+79
New +$17.5K 0.01% 969

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State of Wyoming's NGNE Position: Q2 2026 in Review

State of Wyoming opened a new position in Neurogene (NGNE) in Q2 2026: 980 shares worth $30.8K. The stake represents ﹤0.01% of the portfolio and ranks #1755 among its holdings. This is a return to the name: State of Wyoming previously reported a position in NGNE as recently as Q2 2021.

State of Wyoming first reported a position in NGNE in Q2 2021 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • State of Wyoming held 980 shares of Neurogene worth $30.8K as of Q2 2026.
  • Neurogene was a new State of Wyoming position in Q2 2026.
  • Neurogene made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1755 holding.
  • State of Wyoming first reported a position in Neurogene in Q2 2021 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.